PHLN laboratory procedures and precautions for samples collected from patients with viral haemorrhagic fevers
These procedures explain how laboratories should collect and handle samples from patients with suspected viral haemorrhagic fevers.
We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.
The viral haemorrhagic fevers group of diseases comprises Lassa fever, Congo-Crimean haemorrhagic fever, Ebola and Marburg virus infections.
These guidelines are presented in 2 parts:
- Part A: Guidelines for laboratories that are not associated with a designated isolation hospital
- Part B: Guidelines for laboratories that are associated with a designated isolation hospital